Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRMT112P5 is a pseudogene related to TRMT112, which encodes a protein involved in tRNA methylation and functions as an activator for several tRNA and rRNA methyltransferases. Pseudogenes like TRMT112P5 do not encode functional proteins and are generally not considered therapeutic targets or direct participants in molecular mechanisms for drug interaction, disease, or signaling. There is no evidence for biological function, therapeutic relevance, or disease association for TRMT112P5. The related protein-coding gene TRMT112 encodes an essential cofactor for several methyltransferases involved in RNA modification and has documented roles in methylation, metabolism, and diseases like Galloway-Mowat and Williams-Beuren syndromes. In contrast, TRMT112P5 is a non-functional genomic segment and does not have a direct biological function, molecular classification, or disease role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA methyltransferase subunit 11-2 pseudogene 5 (TRMT112P5).